Home/Investors/Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

11

Top Stage

Pre-clinical

Investment Focus

Genetic Diseases Cystic Fibrosis HIV Infectious Disease Oncology Neglected Tropical Diseases Infectious Diseases Immunology Vaccines Neurology Autoimmune

Portfolio Companies

Company	Stage	Valuation	Focus
Nanite	Pre-clinical	—	Genetic Diseases, Cystic Fibrosis
Sherlock Biosciences	Pre-clinical	—	Infectious Disease, Oncology
Claremont BioSolutions	Commercial	—	—
PAI Life Sciences	Phase 1	—	Neglected Tropical Diseases, Infectious Disease
Afrigen Biologics	preclinical	—	Infectious Diseases, Oncology
Akagera Medicines	phase-1	—	Infectious Diseases, Vaccines
Elixiron Immunotherapeutics	phase-1	—	Neurology, Autoimmune
Schrödinger, Inc.	platform	—	Oncology, Immunology

Frequent Co-Investors

Northpond Ventures1 shared Public Shareholders1 shared Baidu Ventures1 shared National Institutes of Health (NIH)1 shared National Institute of Allergy and Infectious Diseases (NIAID)1 shared Albany Capital1 shared Open Philanthropy Project1 shared National Institute of General Medical Sciences (NIGMS)1 shared